Abstract

Medication-Assisted Treatment (MAT) has emerged as a pivotal strategy in addressing substance use disorders, particularly opioid addiction This review explores evidence-based approaches within MAT, focusing on the integration of pharmacological interventions with comprehensive psychosocial support. Effective MAT programs combine medications such as methadone, buprenorphine, and naltrexone with behavioral therapies, aiming to reduce cravings, prevent relapse, and promote long-term recovery. Key considerations include the selection of appropriate medications based on individual patient profiles, dosage management, and the importance of adherence to treatment protocols.